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2-Aza-2,3_dihydrosqualene (I) and a quaternary ammonium derivative (II) inhibited ergosterol biosynthesis 
in cells and cell-free extracts of the pathogenic yeast Candida albicans as measured by incorporation of ra- 
diolabelled precursors. The compounds inhibited squalene poxidase and 2,3-oxidosqualene cyclase to vary- 
ing degrees in microsomes from C. albicans and from rat liver. The rat liver epoxidase was 50% inhibited 
by I at 2.4 PM. In C. afbicans cells, but not in cell-free extracts, I also inhibited lanosterol demethylation 
and led to accumulation of an unidentified polar product. 
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1. INTRODUCTION 2. EXPERIMENTAL 
The cyclization of squalene to lanosterol in- 
volves sequential action of two enzymes, squalene 
epoxidase (EC 1.14.99.7) and 2,3-epoxysqualene 
lanosterol cyclase (EC 5.4.99.7). Compounds such 
as 2-aza-2,3_dihydrosqualene (I) and 1,l’ ,2-tris- 
nor-3-trimethylammonium squalene iodide (II) 
weri designed by Cattel and co-workers [1,2] as 
analogues of a carbocationic high energy inter- 
mediate of the cyclization. Compounds I and II in- 
hibited cyclases from higher plants and from rat 
liver [3] but effects on other enzymes have not been 
reported. Since I and II are squalene analogues 
they may also inhibit squalene epoxidase. The lat- 
ter enzyme is of considerable practical interest as 
the target of a new class of antimycotic agents, the 
allylamines [4,5]. Surprisingly, the thiocarbamate 
antifungals have also been found to inhibit squa- 
lene epoxidase [6]. In this report we show that I 
and II inhibit both squalene epoxidase and the 
cyclase in microsomes from the pathogenic yeast 
Candida albicans, and from rat liver. 
Compounds I and II were a gift from Professor 
L. Cattel. 
Microsomal squalene epoxidase was assayed as 
described in [5] from rat liver and in [7] for C. 
albicans. The cyclase was measured by conversion 
of 14C-labelled 2,3-epoxidosqualene to sterols as 
described in [8]. Ergosterol biosynthesis in whole 
cells of C. albicans was assayed by incubation with 
[14C]acetate, extraction of the non-saponifiable 
lipids and separation by thin layer chromatography 
as described [8,9]. Sterol biosynthesis in cell-free 
extracts of C. albicans was similarly measured by 
incorporation of [2-14C]mevalonate [9]. 
3. RESULTS 
Incubation of C. albicans cells with I led to a 
dose-dependent inhibition of [14C]acetate incor- 
poration into ergosterol. Inhibition at lower con- 
centrations of I was accompanied by accumulation 
of radioactivity in the fraction corresponding to 
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Table 1 
Effect of I on incorporation of [14C]acetate into non-saponifiable lipid fractions in 
C. albicans cells 
Cont. of I Qo total radioactivity incorporated by 
(M) Ergosterol &-Methyl- 4,CDimethyl- 2,3-Oxido- Squalene 
sterol sterol squalene 
0 (control) 81.2 6.7 6.3 2.1 3.9 
2.4 x lo-’ 75.6 7.0 10.0 2.6 5.0 
2.4 x 1O-6 41.3 7.8 36.4 2.7 11.8 
2.4 x lo-’ 1.4 5.0 6.8 8.0 78.4 
2.4 x 1O-4 0 4.9 1.7 5.4 88.0 
Results are mean of 2 separate xperiments each with triplicate incubations. Mean 
incorporation of radioactivity into total non-saponifiable lipids was 151800 dpm 
lanosterol (4,Cdimethylsterols), whereas at 2.4 x 
lo-’ M and above, radioactivity accumulated in 
2,3-oxidosqualene and squalene (table 1). This was 
confirmed by autoradiography which also revealed 
accumulation of radioactivity in a more polar frac- 
tion, which was not identified (fig.1). A similar 
pattern of labelling was observed in cells incubated 
with II, except hat no accumulation of activity oc- 
curred in the lanosterol fraction. These effects 
were observed in several independent experiments. 
Addition of I to a C. albicans cell-free system 
also caused a dose-dependent inhibition of incor- 
poration of [14C]mevalonate into ergosterol, with 
accumulation in 2,3-oxidosqualene and squalene 
(table 2). Inhibitor II showed a similar effect. 
There was no accumulation of radioactivity in 
4,4_dimethylsterol or in the unidentified polar 
fraction, confirmed by autoradiography of the 
type shown in fig.1. 
Compounds I and II (up to 2.4 x 10v4 M) had no 
significant effect on incorporation of either acetate 
or mevalonate into the total non-saponifiable 
lipids in C. afbicans. There was thus no evidence 
for inhibition of steps earlier than squalene epox- 
idase. 
Table 3 summarizes the inhibitory effects of I 
and II on the microsomal squalene epoxidase and 
cyclase enzymes. Both compounds inhibited the 
cyclase enzymes from rat liver and C. albicans, as 
expected from existing reports [l-3]. Compound I 
was also an effective inhibitor of squalene epox- 
idase, the rat liver epoxidase being the most sen- 
sitive of all the test systems employed. Although 
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this latter inhibition was quantitatively reproduci- 
ble, Lineweaver-Burk plots were variable between 
experiments and failed to show a pattern typical of 
either competitive or non-competitive inhibition. 
1 2 8 1L 5 
Fig.1. Autoradiograph of TLC separation of labelled 
non-saponifiable lipids from C. albicans cells incubated 
with [14C]acetate in the presence of different concentra- 
tions of I. Concentration of I is: (1) control; (2) 2.4 x 
lo-’ M; (3) 2.4 x 1O-6 M; (4) 2.4 x lo-’ M; (5) 2.4 x 
10e4 M. SF, solvent front; SQ, squalene; OS, 2,3-oxido- 
squalene; L, lanosterol; M, &-methylsterols; E, ergo- 
sterol; U, unidentified; 0, origin. 
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Table 2 
Effect of I on incorporation of [‘4C]meva10nate into non-saponifiable lipid frac- 
tions in C. ulbicans cell-free extract 
Cont. of I 
CM) 
% total radioactivity incorporated by 
Ergosterol k-Methyl- 4,4-Dimethyl- 2,3-Oxide- Squalene 
sterol sterol squalene 
0 (control) 7.5 5.6 6.9 7.8 72.4 
2.4 x IO-’ 7.2 5.4 7.1 8.8 71.7 
2.4 x 1O-6 5.4 5.2 6.5 9.5 73.6 
2.4 x lo-’ 1.3 4.0 3.5 12.1 79.1 
2.4 x 1O-4 0 3.7 1.3 6.5 88.6 
Results are mean of 2 separate xperiments each with triplicate incubations. Mean 
incorporation of radioactivity into total non-saponifiable lipids was 158 800 dpm 
Table 3 
Inhibitory effects of I and II on sterol biosynthesis en- 
zymes in C. albicuns and rat liver 
C. albino epoxidase 
Rat liver epoxidase 
C. albicans cyclase 
Rat liver cyclase 
C. albicuns whole cells 
C. ulbicuns cell-free 
150 values &M) 
I II 
32.9 63.0 
2.4 90.0 
6.5 13.3 
32.2 5.8 
2.5 20.7 
6.6 3.4 
Squalene epoxidase, 2,3-oxidosqualene cyclase and 
measurement of ergosterol biosynthesis in whole cells 
and cell-free extracts were performed as outlined in sec- 
tion 2. Values are mean of 2 independent experiments 
The lack of specificity and the effects on mam- 
malian enzymes appear to rule out these deriva- 
tives as potential antifungal agents, but they may 
be of interest in the development of hypocholester- 
olemic agents. 
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4. DISCUSSION 
The similarity to squalene of I and II would sug- 
gest them to be competitive inhibitors of both 
squalene epoxidase and cyclase. Duriatti et al. [3] 
observed non-competitive kinetics for the inhibi- 
tion of the cyclase by I, this unexpected result be- 
ing accounted for by the limitations imposed by a 
highly lipophilic inhibitor and substrate. This was 
probably the reason for our failure to obtain satis- 
factory kinetic plots for the squalene epoxidase in- 
hibition in rat liver microsomes. 
Our results show direct inhibition of both squa- 
lene epoxidase and cyclase by I in C. ~~~~~~ns 
microsomes. In whole cells of this fungus there was 
evidence for further, indirect, inhibition of lano- 
sterol demethylation and of some other as yet 
undefined reaction, It is conceivable that intra- 
cellular metabolism of I could lead to formation of 
other inhibitors, possibly azasteroids which are 
known to inhibit various stages of ergosterol bio- 
synthesis [lO,ll]. 
We thank Professor L. Cattel for his generous 
gift of compounds I and II. 
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